Completed PHASE3 INTERVENTIONAL 5-arm NCT03879772

Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)

Dose-Ranging Study of Mometasone Furoate Nasal Spray (SCH 32088) in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (Protocol C95-161)

Sponsor: Organon and Co

Conditions Rhinitis, Allergic, Seasonal

Interventions Beclomethasone dipropionate nasal spray Chlorpheniramine maleate syrup Mometasone furoate nasal spray Placebo nasal spray

Updated 7 times since 2019 Last updated: Feb 7, 2022 Started: Mar 12, 1996 Primary completion: Jul 1, 1996 Completion: Jul 1, 1996

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Rhinitis, Allergic, Seasonal, this trial is completed. The trial is conducted by Organon and Co and has accumulated 7 data snapshots since 1996. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2022 — Jul 2024 [monthly]

Completed PHASE3
Dec 2021 — Mar 2022 [monthly]

Completed PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Sep 2019 — Jan 2021 [monthly]

Completed PHASE3
Apr 2019 — Sep 2019 [monthly]

Completed PHASE3

First recorded

Mar 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Organon and Co

Data source: Organon and Co

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.